News & Videos - English - Page 2

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Caribou To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Caribou between July 14, 2023 and July 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] New York, New...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Enphase Energy To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Enphase Energy between April 25, 2023 and October 22, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] New...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Zeta To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Zeta between February 27, 2024 and November 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] New York, New...

APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Jan. 11, 2025 NEW YORK , Jan. 11, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024 , both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline. So what: If you purchased Applied Therapeutics...

...

New York, New York--(Newsfile Corp. - January 11, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Symbotic securities during the Class Period you may be entitled to compensation without...

Both countries exchanged drone attacks early on Saturday morning, injuring two in Zaporizhzhia in Ukraine and at least seven in ......

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Kyverna To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing Kyverna common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about February 8, 2024 (the "IPO" or "Offering") and would like to discuss your legal...

Angelina Jolie says although she appreciates being an artist, she would much prefer for her own legacy to be "a good mother"....

Catch up with the most important stories from around Europe and beyond - latest news, breaking news, World, Business, ......

Learn the five biggest crypto fails of all time. ITRUST $100 BONUS https://itrust.capital/LarkDavis GET MY FREE ......

...

The weekslong standoff between supporters and opponents of suspended South Korean President Yoon Suk Yeol continues....

shorts #europeanparliament #europeanunion #medialiteracy #disinformation....

From the ongoing wildfires ravaging parts of California to Biden banning oil and drilling in U.S. coastal waters and Trump's interest ......

...

Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). PR Newswire CHENGDU, China, Jan. 11, 2025 CHENGDU, China , Jan. 11, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (together with the Company, the "Licensors"), have entered into an exclusive license agreement (the "License Agreement") with...

HONG KONG, HK / ACCESSWIRE / January 11, 2025 / Inverteum Capital, an algorithmic trading firm, today announced its exceptional performance for the year 2024, marking a significant milestone in the company's history. Inverteum achieved a remarkable 40% total return, significantly outperforming the S&P 500 Index, which returned 25% in 2024. The firm also reported a trading volume of US$44 million in 2024, underscoring its growing influence in the financial markets. A Year of Milestones 2024 was a...

UK Chancellor of the Exchequer Rachel Reeves and Chinese Vice Premiere He Lifeng deliver joint remarks, after attending the ......

Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). PR Newswire CHENGDU, China, Jan. 11, 2025 CHENGDU, China , Jan. 11, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (together with the Company, the "Licensors"), have entered into an exclusive license agreement (the "License Agreement") with...